Seres Therapeutics MCRB
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2026Q1 | 8.87 | 26 | -56.32 | -20 | -15.57 | 118 |
| 2025Q4 | 14.88 | 44 | -34.89 | -15 | -10.89 | 138 |
| 2025Q3 | 19.24 | 44 | 21.41 | 8 | 5.71 | 143 |
| 2025Q2 | 11.11 | 33 | -47.61 | -20 | -12.89 | 144 |
| 2025Q1 | 14 | 50 | 101.74 | 33 | 21.5 | 164 |
| 2024Q4 | 16.62 | 14 | -82.95 | -16 | -9.82 | 140 |
| 2024Q3 | 18.92 | 24 | 89 | 35.48 | 179 | |
| 2024Q2 | 14.48 | -87 | -33 | -9.92 | 322 | |
| 2024Q1 | 15.48 | -60 | -40 | -11.47 | 341 | |
| 2023Q4 | 28 | -45 | -41 | -11.36 | 359 | |
| 2023Q3 | 47.6 | -15 | -48 | -12.36 | 368 | |
| 2023Q2 | 95.8 | 23 | 47 | 13.76 | 406 | |
| 2023Q1 | 113.4 | -48 | -71 | -23 | 270 | |
| 2022Q4 | 112 | 11 | -175.57 | -69 | -20.83 | 349 |
| 2022Q3 | 128.4 | 68 | -132.39 | -60 | -20.51 | 312 |
| 2022Q2 | 68.6 | 23 | -124.47 | -65 | -21.83 | 273 |
| 2022Q1 | 142.4 | 81 | -53.3 | -57 | -16.78 | 320 |
| 2021Q4 | 166.6 | 132 | -32.55 | -50 | -13.31 | 355 |
| 2021Q3 | 139.2 | 176 | 49.29 | 68 | 20.49 | 396 |
| 2021Q2 | 477 | 101 | -39.49 | -48 | -16.8 | 270 |